Related Experiment Videos
Neonatal flumazenil therapy reverses maternal diazepam
J C Dixon1, B D Speidel, J J Dixon
1Department of Neonatal Medicine, Southmead Hospital, Westbury-on-Trym, Bristol, UK.
Acta Paediatrica (Oslo, Norway : 1992)
|March 25, 1998
Summary
Flumazenil reversed persistent infant apnea caused by maternal diazepam administration during pregnancy. This finding highlights flumazenil
Area of Science:
- Obstetrics and Gynecology
- Neonatal Medicine
- Clinical Pharmacology
Background:
- Eclampsia is a severe complication of pregnancy characterized by seizures.
- Diazepam, a benzodiazepine, is sometimes used to manage seizures in eclampsia.
- Neonatal outcomes can be affected by maternal medication use during pregnancy.
Observation:
- A neonate experienced persistent apnea and required respiratory support following maternal administration of diazepam before an emergency cesarean section.
- The infant's spontaneous respiration returned only after initiating an intravenous infusion of flumazenil.
Findings:
- Flumazenil effectively reversed the respiratory depression in the neonate.
- Assays confirmed the presence of diazepam and its active metabolites during flumazenil treatment.
Implications:
- Flumazenil may serve as a crucial antidote for benzodiazepine-induced respiratory depression in neonates.
- This case suggests a potential therapeutic role for flumazenil in managing neonatal complications arising from maternal diazepam exposure.
- Further research is warranted to establish optimal dosing and safety profiles of flumazenil in this context.